Patents by Inventor Amr HAMED

Amr HAMED has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Delta-opioid receptor agonists
    Patent number: 11787787
    Abstract: The present disclosure relates to novel ?-opioid receptor agonists, and the method of making and using the novel ?-opioid receptor agonists. The novel ?-opioid receptor agonists are selective ?-opioid receptor agonists that have substantially no beta-arrestin 2 recruitment or low beta-arrestin 2 recruitment. The novel ?-opioid receptor agonists may be used for the treatment for alcohol use disorders and other co-occurring psychiatric disorders.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: October 17, 2023
    Assignee: Purdue Research Foundation
    Inventors: Richard M Van Rijn, Mark S Cushman, Markus Lill, Robert J Cassell, Amr Hamed Mahmoud Abdallah, Mohamed S. A. Elsayed
  • CUSTOMIZED DENTAL VENEERS
    Publication number: 20210322134
    Abstract: Described is a customized removable cosmetic or aesthetic dental veneer that secures onto a row of teeth of a patient. The dental veneer may include a pair of rear portions that secure it onto the row of teeth, each rear portion positioned at a distal end of the veneer and having: buccal, occlusal and lingual sides for one or more rear tooth, and a front portion between the pair of rear portions that covers the buccal and occlusal surfaces of the teeth between the pair of rear portions but is free of a side that covers a majority of the lingual surface of any tooth of the row of teeth between the pair of rear portions. A slot and apertures may also be provided for occlusal portions of the rear teeth. Also described is a veneer without such rear portions, which may be used with an adhesive.
    Type: Application
    Filed: April 15, 2021
    Publication date: October 21, 2021
    Inventors: Amr HAMED, Mohamed SHAMSELDEEN
  • DELTA-OPIOID RECEPTOR AGONISTS
    Publication number: 20210155614
    Abstract: The present disclosure relates to novel ?-opioid receptor agonists, and the method of making and using the novel ?-opioid receptor agonists. The novel ?-opioid receptor agonists are selective ?-opioid receptor agonists that have substantially no beta-arrestin 2 recruitment or low beta-arrestin 2 recruitment. The novel ?-opioid receptor agonists may be used for the treatment for alcohol use disorders and other co-occurring psychiatric disorders.
    Type: Application
    Filed: February 2, 2021
    Publication date: May 27, 2021
    Applicant: Purdue Research Foundation
    Inventors: Richard M. Van Rijn, Mark S. Cushman, Markus Lill, Robert J. Cassell, Amr Hamed Mahmoud Abdallah, Mohamed S.A. Elsayed
  • Delta-opioid receptor agonists
    Patent number: 10954224
    Abstract: The present disclosure relates to novel ?-opioid receptor agonists, and the method of making and using the novel ?-opioid receptor agonists. The novel ?-opioid receptor agonists are selective ?-opioid receptor agonists that have substantially no beta-arrestin 2 recruitment or low beta-arrestin 2 recruitment. The novel ?-opioid receptor agonists may be used for the treatment for alcohol use disorders and other co-occurring psychiatric disorders.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: March 23, 2021
    Assignee: Purdue Research Foundation
    Inventors: Richard M Van Rijn, Mark S Cushman, Markus Lill, Robert J Cassell, Amr Hamed Mahmoud Abdallah, Mohamed S. A. Elsayed
  • NOVEL DELTA-OPIOID RECEPTOR AGONISTS
    Publication number: 20200199111
    Abstract: The present disclosure relates to novel ?-opioid receptor agonists, and the method of making and using the novel ?-opioid receptor agonists. The novel ?-opioid receptor agonists are selective ?-opioid receptor agonists that have substantially no beta-arrestin 2 recruitment or low beta-arrestin 2 recruitment. The novel ?-opioid receptor agonists may be used for the treatment for alcohol use disorders and other co-occurring psychiatric disorders.
    Type: Application
    Filed: June 8, 2018
    Publication date: June 25, 2020
    Applicant: Purdue Research Foundation
    Inventors: Richard M Van Rijn, Mark S Cushman, Markus Lill, Robert J Cassell, Amr Hamed Mahmoud Abdallah, Mohamed S.A. Elsayed